BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6205695)

  • 41. Influence of the human pancreatic secretory trypsin inhibitor on trypsin-induced C3 and kininogen cleavage: an in vitro study.
    Ohlsson K
    Scand J Gastroenterol Suppl; 1986; 126():18-20. PubMed ID: 2436281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cleavage of peptide hormones by alpha 2-macroglobulin-trypsin complex and its relation to the pathogenesis and chemotherapy of acute pancreatitis.
    Hermon-Taylor J; Magee AI; Grant DA; Jones PA; Marshall CE; Dunham J
    Clin Chim Acta; 1981 Jan; 109(2):203-9. PubMed ID: 6162593
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Conformational aspects of beta-trypsin interaction with substrates and pancreatic trypsin inhibitor. I. Conformational properties of residues in the enzyme-active center and the structure of a non-valent enzyme-substrate complex].
    Godzhaev NM; Aliev RE; Popov EM
    Mol Biol (Mosk); 1986; 20(1):102-19. PubMed ID: 3951435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trypsin binding activity of alpha 2-macroglobulin in cystic fibrosis and other lung diseases.
    Schidlow DV; Kueppers F
    Am Rev Respir Dis; 1980 Jan; 121(1):31-7. PubMed ID: 6153257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interactions in vitro and in vivo between anionic and cationic porcine trypsin and porcine plasma proteinase inhibitors.
    Hjelmqvist B; Borgström A; Ohlsson K
    Biol Chem Hoppe Seyler; 1988 Dec; 369(12):1331-6. PubMed ID: 3242553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Purification and characterization of an alpha-macroglobulin proteinase inhibitor from the mollusc Octopus vulgaris.
    Thøgersen IB; Salvesen G; Brucato FH; Pizzo SV; Enghild JJ
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):521-7. PubMed ID: 1379044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on proteases and alpha-macroglobulin activity in amphibian blood plasma.
    Kumar RS
    Indian J Exp Biol; 1997 Nov; 35(11):1198-202. PubMed ID: 9567750
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Site-directed mutagenesis of human pancreatic secretory trypsin inhibitor.
    Kikuchi N; Nagata K; Shin M; Mitsushima K; Teraoka H; Yoshida N
    J Biochem; 1989 Dec; 106(6):1059-63. PubMed ID: 2628423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Binding of proteinases to human alpha 2-macroglobulin with its thioester bonds cleaved by methylamine in the presence of a thiol-group-cyanylating reagent.
    Björk I
    Biochem J; 1985 Oct; 231(2):451-7. PubMed ID: 2415116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ligand binding, conformational change and plasma elimination of human, mouse and rat alpha-macroglobulin proteinase inhibitors.
    Gonias SL; Balber AE; Hubbard WJ; Pizzo SV
    Biochem J; 1983 Jan; 209(1):99-105. PubMed ID: 6189480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hamster alpha-macroglobulin and murinoglobulin: comparison of chemical and biological properties with homologs from other mammals.
    Miyake Y; Shinomura M; Ito T; Yamamoto K; Abe K; Amemiya S; Sinohara H
    J Biochem; 1993 Oct; 114(4):513-21. PubMed ID: 7506251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Partition of trypsin and Kazal inhibitor in reaction mixtures with human serum.
    Eddeland A
    Hoppe Seylers Z Physiol Chem; 1979 Feb; 360(2):145-9. PubMed ID: 422124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of protein substrate and inhibitors with alpha 2-macroglobulin-bound proteinases.
    Bieth JG; Kandel MJ; Zreika M; Pochon F
    Ann N Y Acad Sci; 1983; 421():209-17. PubMed ID: 6202196
    [No Abstract]   [Full Text] [Related]  

  • 54. [Study of the complex between porcine plasmin and alpha2-macroglobulin (author's transl)].
    Jacquot-Armand Y; Guinand S
    Biochim Biophys Acta; 1976 Jun; 438(1):239-49. PubMed ID: 59608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Levels of alpha 1-antitrypsin and alpha 2-macroglobulin in blood serum and its antitryptic capacity].
    Protsenko VA; Veselov VF; Protsenko AV; Kiriukhin IF; Kosik OG
    Ukr Biokhim Zh (1978); 1982; 54(4):377-82. PubMed ID: 6182660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human alpha2-macroglobulin and its antitrypsic and antithrombin activities in serum and plasma.
    de Vonne TL; Mouray H
    Clin Chim Acta; 1978 Nov; 90(1):83-5. PubMed ID: 82495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trypsin activation. Effect of the Ile-Val dipeptide concentration on Kazal inhibitor binding to bovine trypsinogen.
    Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
    Biochim Biophys Acta; 1985 Dec; 832(3):378-82. PubMed ID: 4074755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Purification of alpha 2-macroglobulin with trypsin-like activity from pleural fluids.
    Bieth J; Klumpp T
    Biochim Biophys Acta; 1976 Aug; 439(2):363-7. PubMed ID: 60136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A mutant trypsin-like enzyme from Streptomyces fradiae, created by site-directed mutagenesis, improves affinity chromatography for protein trypsin inhibitors.
    Katoh T; Kikuchi N; Nagata K; Yoshida N
    Appl Microbiol Biotechnol; 1996 Aug; 46(1):15-21. PubMed ID: 8987530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetic mechanism of the inhibition of human urinary kallikrein by basic pancreatic trypsin inhibitor.
    Miranda TL; Ramos CH; Freire RT; Souza EP; Rogana E; Santoro MM; Figueiredo AF
    Braz J Med Biol Res; 1995 May; 28(5):505-12. PubMed ID: 8555969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.